Advanced Neuromodulation Technologies for the Treatment of Chronic Pain

The Mannheim Center for Neuromodulation and Neuroprosthetics (MCNN) at the UMM, has rapidly developed into an innovative interdisciplinary center for neuromodulation, neuroprosthetics, and neurotechnology. Within its first year, several major research initiatives were successfully launched, enabling the implementation of cutting-edge technologies for the treatment of chronic pain and the development of AI-based approaches in neuroscience.

A major milestone is the introduction of High Intensity Focused Ultrasound (HiFu), one of the most advanced non-invasive technologies currently available for the treatment of chronic pain. In combination with magnetic resonance imaging, the technology enables highly precise focused ultrasound procedures with real-time monitoring of the targeted brain region during thermal treatment. Beyond chronic pain, this approach also holds considerable potential for future neurological and psychiatric applications.

In October 2024, Thomas Kinfe was appointed to the endowed professorship for “Neuromodulation and Neuroprosthetics.” He now leads the newly established Section for Neuromodulation and Neuroprosthetics within the Department of Neurosurgery at the UMM together with an associated translational research program. Shortly thereafter, the MCNN was founded as a collaborative initiative involving the University Medical Center Mannheim, the Central Institute of Mental Health, and the BG Clinic Ludwigshafen.

Under the direction of Professor Kinfe, the center integrates the disciplines of neuromodulation, neuroprosthetics, neurotechnology, and neuro-AI with the aim of developing innovative therapeutic strategies for movement disorders, chronic pain syndromes, and other neurological and psychiatric conditions. The MCNN combines expertise in “Chronic Pain and Neuromodulation,” “Translational Neuromodulation,” “Neuro-AI and Brain-Computer Interfaces,” and “Physics and Cognition,” thereby creating a unique interdisciplinary platform linking clinical care, engineering, computational neuroscience, and basic research.

Neuromodulation is a subspecialty of functional neurosurgery in which neuronal networks in the brain and spinal cord are specifically modulated using electrical stimulation. These approaches are increasingly used to treat disorders such as Parkinson's disease, chronic pain syndromes, epilepsy, psychiatric disorders, and functional impairments affecting speech or motor function.

Another major research focus of the MCNN is the development of predictive neuro-AI models for neuromodulation. Current projects aim to improve the understanding of neurobiological mechanisms underlying chronic pain and auditory phantom perceptions such as Tinnitus. Artificial intelligence is applied both as a computational modeling framework and as a methodological tool for the analysis of complex neural systems.

The projects exemplify the close interdisciplinary and cross-institutional collaboration between clinical neuroscience, engineering, artificial intelligence, and translational medicine in the Rhine-Neckar metropolitan region.

These projects are supported by the Dr. Rolf M. Schwiete Foundation and the German Research Foundation (DFG).

Professor Thomas Kinfe and Professor Andreas Meyer-Lindenberg are Core Members of the Mannheim Center for Translational Neurosciences (MCTN) and members of the Mannheim Comprehensive Neuroscience Campus (MCNC), underscoring the close interdisciplinary collaboration between the participating institutions within the neuroscience focus area at the Medical Faculty Mannheim.